As MISSD approaches the end of another incredible year, we want to express our heartfelt gratitude for your support that enabled us to achieve remarkable milestones in 2023. We’re excited to continue making a positive difference in the coming year. Our 2024 public health ads will reach Canada, Australia and several new cities across the US. We’ll also be presenting at multiple conferences from DC to Kansas City and points in between.
With the year-end fast approaching, there’s still time to make a tax-deductible donation for 2023. Your support is essential in helping us continue our vital work.
Together, we are increasing awareness of akathisia and related adverse drug effects that can negatively impact mental health and public safety. Once again, thank you for being an integral part of our MISSD family. We can’t wait to embark on another year of progress and change with you by our side.
More than 30 prominent figures in critical psychiatry have published a recent article in the British Medical Journal (BMJ) “calling on the UK government to acknowledge the evidence that antidepressants are no better than placebos for most patients and to increase funding of social and psychological interventions while decreasing drug prescriptions. Following these guidelines can reduce akathisia & related prescribed harm. Read more at https://www.madinamerica.com/2023/12/stop-using-antidepressants-except-for-the-most-severe-depression-experts-say/.
